Cargando…
The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion
Intestinal ischemia-reperfusion (II/R) develops when the blood flow to the intestines decreases, followed by the reestablishment of the blood supply to the ischemic tissue, resulting in intestinal mucosal barrier dysfunction, with consequent severe local and systemic inflammation. Acute lung injury...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378771/ https://www.ncbi.nlm.nih.gov/pubmed/34434495 http://dx.doi.org/10.18632/oncotarget.28041 |
_version_ | 1783740877763510272 |
---|---|
author | Casili, Giovanna Scuderi, Sarah Adriana Lanza, Marika Filippone, Alessia Basilotta, Rossella Mannino, Deborah Campolo, Michela Esposito, Emanuela Paterniti, Irene |
author_facet | Casili, Giovanna Scuderi, Sarah Adriana Lanza, Marika Filippone, Alessia Basilotta, Rossella Mannino, Deborah Campolo, Michela Esposito, Emanuela Paterniti, Irene |
author_sort | Casili, Giovanna |
collection | PubMed |
description | Intestinal ischemia-reperfusion (II/R) develops when the blood flow to the intestines decreases, followed by the reestablishment of the blood supply to the ischemic tissue, resulting in intestinal mucosal barrier dysfunction, with consequent severe local and systemic inflammation. Acute lung injury (ALI) represents the most serious complication after II/R. KYP-2047 is a selective inhibitor of prolyl oligopeptidase (POP), a serine protease involved in the release of pro-angiogenic and inflammatory molecules. The aim of the present study is to assess the effects of POP-inhibition mediated by KYP-2047 treatment in the pathophysiology of ALI following II/R. An in vivo model of II/R was performed and mice were subjected to KYP-2047 treatment (intraperitoneal, 1, 2.5 and 5 mg/kg). Histological analysis, Masson’s trichrome staining, immunohistochemical, immunofluorescence, biochemical and western blots analysis were performed on ileum and lung samples. KYP-2047 treatment ameliorated histological alteration in ileum and lung, reduced collagen amount and lowered inflammatory protein levels. Moreover, TGF-β1, eNOS, VEGF and CD34 positive staining has been modulated; also, a reduction in apoptosis expression was confirmed. This research revealed the strong anti-inflammatory potential of KYP-2047 associated to its modulatory role on angiogenesis and apoptosis, suggesting POP as a novel therapeutic target for ALI after II/R. |
format | Online Article Text |
id | pubmed-8378771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-83787712021-08-24 The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion Casili, Giovanna Scuderi, Sarah Adriana Lanza, Marika Filippone, Alessia Basilotta, Rossella Mannino, Deborah Campolo, Michela Esposito, Emanuela Paterniti, Irene Oncotarget Research Paper Intestinal ischemia-reperfusion (II/R) develops when the blood flow to the intestines decreases, followed by the reestablishment of the blood supply to the ischemic tissue, resulting in intestinal mucosal barrier dysfunction, with consequent severe local and systemic inflammation. Acute lung injury (ALI) represents the most serious complication after II/R. KYP-2047 is a selective inhibitor of prolyl oligopeptidase (POP), a serine protease involved in the release of pro-angiogenic and inflammatory molecules. The aim of the present study is to assess the effects of POP-inhibition mediated by KYP-2047 treatment in the pathophysiology of ALI following II/R. An in vivo model of II/R was performed and mice were subjected to KYP-2047 treatment (intraperitoneal, 1, 2.5 and 5 mg/kg). Histological analysis, Masson’s trichrome staining, immunohistochemical, immunofluorescence, biochemical and western blots analysis were performed on ileum and lung samples. KYP-2047 treatment ameliorated histological alteration in ileum and lung, reduced collagen amount and lowered inflammatory protein levels. Moreover, TGF-β1, eNOS, VEGF and CD34 positive staining has been modulated; also, a reduction in apoptosis expression was confirmed. This research revealed the strong anti-inflammatory potential of KYP-2047 associated to its modulatory role on angiogenesis and apoptosis, suggesting POP as a novel therapeutic target for ALI after II/R. Impact Journals LLC 2021-08-17 /pmc/articles/PMC8378771/ /pubmed/34434495 http://dx.doi.org/10.18632/oncotarget.28041 Text en Copyright: © 2021 Casili et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Casili, Giovanna Scuderi, Sarah Adriana Lanza, Marika Filippone, Alessia Basilotta, Rossella Mannino, Deborah Campolo, Michela Esposito, Emanuela Paterniti, Irene The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
title | The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
title_full | The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
title_fullStr | The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
title_full_unstemmed | The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
title_short | The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
title_sort | protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378771/ https://www.ncbi.nlm.nih.gov/pubmed/34434495 http://dx.doi.org/10.18632/oncotarget.28041 |
work_keys_str_mv | AT casiligiovanna theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT scuderisarahadriana theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT lanzamarika theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT filipponealessia theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT basilottarossella theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT manninodeborah theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT campolomichela theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT espositoemanuela theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT paternitiirene theprotectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT casiligiovanna protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT scuderisarahadriana protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT lanzamarika protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT filipponealessia protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT basilottarossella protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT manninodeborah protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT campolomichela protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT espositoemanuela protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion AT paternitiirene protectiveroleofprolyloligopeptidasepopinhibitioninacutelunginjuryinducedbyintestinalischemiareperfusion |